Company / SG&A per Share
Roivant Sciences SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.60
FY2025
5-year range
$0.40 / $1.16
FY2021-FY2025
Trend
-18.4%
vs FY2024
Sector context
#156 of 210
Health Care
What the data says
At $0.60, Roivant Sciences's sg&a per share ranks #55 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 6 years, ranging from $0.40 in FY2022 to $1.16 in FY2021.
Based on SEC 10-K filings.
0.60 in FY2025 with a 5-year CAGR of +7.7%.
Improved from $0.90 to $0.60 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +14.5%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Sector benchmark
#55 of 210 in Health CareTop 26% of 210This company $0.60 Sector average $29.50
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 18.4% year-over-year.
- Ranks #156 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2021.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.60 | -18.4% |
| FY2024 | $0.73 | -18.9% |
| FY2023 | $0.90 | +126.7% |
| FY2022 | $0.40 | -65.5% |
| FY2021 | $1.16 | +180.5% |
| FY2020 | $0.41 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026